<?xml version="1.0" encoding="UTF-8"?>
<p>Influenza virus has been associated with mortality and morbidity in chronic lung diseases (
 <xref ref-type="bibr" rid="B36">Harper et al., 2009</xref>). A meta-analysis showed that influenza vaccination prevented exacerbations in COPD patients (
 <xref ref-type="bibr" rid="B88">Poole et al., 2000</xref>) and reduced the mortality and morbidity in elderly persons (
 <xref ref-type="bibr" rid="B75">Nichol et al., 2007</xref>). Anti-viral treatment such as neuraminidase inhibitors may reduce the severity of disease (
 <xref ref-type="bibr" rid="B52">Kaiser et al., 2003</xref>). Thus, treatment to prevent influenza has been recommended for COPD patients (
 <xref ref-type="bibr" rid="B36">Harper et al., 2009</xref>).
</p>
